CLYM - Prakiraan volume dodolan Climb Bio Inc
The strategy of Climb Bio Inc (CLYM) focuses on financing the initial stages of biomolecule testing. Analyzing the chart on GURU.Markets, we find that the company's projected revenue has stabilized at 0.00. Drug production has been outsourced to external CDMO partners to minimize operational risks. Meanwhile, the synthesis of drugs for autoimmune pathologies is being automated by algorithms, although clinical control remains with physicians.
Rincian analitis lan laporan data perusahaan Climb Bio Inc. (CLYM)
- nilai saham lan prakiraan konsensus rega:
- statistik kapitalisasi pasar:
- informasi kapitalisasi buku:
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal Climb Bio Inc|CLYM - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Climb Bio, Inc.|CLYM - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Climb Bio, Inc.|CLYM - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Climb Bio|Rasio cepet climbbio.com
- statistik bathi lan rasio pasar:
CLYM - Bathi resik perusahaan|Proyeksi bathi mangsa ngarep Climb Bio Inc|CLYM - Periode bali modal bisnis|Rega marang bathi mangsa ngarep Climb Bio|CLYM - Rega marang bathi kanthi panyesuaian wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Climb Bio, Inc.|CLYM - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Climb Bio|CLYM - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan climbbio.com|CLYM - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Climb Bio Inc
- data total pendapatan lan volume dodolan:
Analisis fundamental perusahaan:Climb Bio Inc
Amid intense competition and the risks of clinical trial failure for Climb Bio Inc (CLYM), the firm's projected sales level serves as an indicator of the market consensus regarding the commercial success of future drugs. This metric aggregates analyst revenue forecasts, allowing investors to compare current market capitalization with expected operational efficiency and avoid overpaying for the asset's speculative growth.
Perusahaan pesaing
Prakiraan pendapatan perusahaan argenx SE (ARGX)|biontech.de - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan ABVX (Abivax S.A.)|ADMA Biologics Inc (ADMA) - Volume dodolan sing dikarepake perusahaan|Protagonist Therapeutics Inc - Prakiraan volume dodolan|Immunovant Therapeutics (IMVT) - Volume dodolan mangsa ngarep perusahaan|Kiniksa Pharmaceuticals (KNSA) - Prakiraan pendapatan perusahaan|GRFS (grifols.com) - Prakiraan pendapatan perusahaan|ADPT (Adaptive Biotechnologies Corporation) - Prakiraan volume dodolan|Celldex Therapeutics Inc (CLDX) - Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Aurinia Pharma (AUPH)|Volume dodolan mangsa ngarep perusahaan BioCryst Corp BCRX|Prakiraan volume dodolan VERA (Vera Therapeutics, Inc.)|dianthustx.com - Prakiraan pendapatan perusahaan|PHVS: Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan ABCL (AbCellera Biologics Inc.)|TRML: Prakiraan volume dodolan|PGEN (Precigen Corp) - Prakiraan pendapatan perusahaan|PHAR (Pharming Group N.V.) - Prakiraan volume dodolan|nektar.com (NKTR) - Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Upstream Bio (UPB)|ZBIO - Volume dodolan sing dikarepake perusahaan|Immunome Corp - Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan GOSS|KalVista Pharmaceuticals - Prakiraan volume dodolan|Dodolan mangsa ngarep perusahaan septerna.com SEPN|Pieris Pharmaceuticals, Inc. (PVLA) - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan SVRA|RIGL (Rigel Pharmaceuticals Inc) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan AnaptysBio Inc. (ANAB)|Prakiraan volume dodolan ATXS|Volume dodolan mangsa ngarep perusahaan engene.com ENGN|Prakiraan pendapatan perusahaan RAPT Therapeutics RAPT|Aerovate Therapeutics, Inc. - Prakiraan pendapatan perusahaan|ACRS: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan Kyverna Therapeutics, Inc|Tiziana Life Sciences (TLSA) - Prakiraan pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan cabalettabio.com|Prakiraan pendapatan perusahaan Ventyx Biosciences, Inc.|Theratechnologies, Inc. - Pendapatan sing dikarepake perusahaan|Prakiraan volume dodolan AVTX|ELDN (Eledon Pharmaceuticals, Inc) - Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan AGEN (Agenus)|Prakiraan volume dodolan zurabio.com ZURA|ATYR - Prakiraan pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan ADAG (Adagene)|ikenaoncology.com (IMA) - Prakiraan pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan Shattuck Labs|EQ (Equillium Inc) - Prakiraan volume dodolan|Prakiraan volume dodolan Connect Pharma|Volume dodolan mangsa ngarep perusahaan IMUX (Immunic, Inc.)|ATRA (atarabio.com) - Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan IFRX (InflaRx)|Dodolan mangsa ngarep perusahaan X4 Pharmaceuticals, Inc (XFOR)|ACET - Prakiraan pendapatan perusahaan|Celularity Inc. (CELU) - Volume dodolan mangsa ngarep perusahaan|INmune Bio (INMB) - Prakiraan pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan Barinthus Biotherapeutics PLC|Volume dodolan mangsa ngarep perusahaan KZR|Prakiraan volume dodolan SAB Biotherapeutics Inc|Prakiraan pendapatan perusahaan Akari Therapeutics (AKTX)|enlivex.com - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan QTTB (Q32 Bio)|GeoVax Labs (GOVX) - Volume dodolan sing dikarepake perusahaan|Edesa - Prakiraan volume dodolan|iBio Corporation (IBIO) - Volume dodolan mangsa ngarep perusahaan|carismatx.com (CARM) - Prakiraan pendapatan perusahaan|XTLB (xtlbio.com) - Prakiraan pendapatan perusahaan|BOLT (Bolt Biotherapeutics Inc.) - Prakiraan volume dodolan|HCW Biologics Inc (HCWB) - Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Aptevo Therapeutics (APVO)|Volume dodolan mangsa ngarep perusahaan aimimmuno.com AIM|Prakiraan volume dodolan ADTX (Aditxt, Inc.)|gribio.com - Prakiraan pendapatan perusahaan|XRTX: Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan HIND (Vyome Holdings Inc.)|REVB: Prakiraan volume dodolan|INDP (Indaptus Corp) - Prakiraan pendapatan perusahaan|SCNI (Scinai Immunotherapeutics) - Prakiraan volume dodolan|CalciMedica Corp (CALI) - Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Affimed (AFMD)|ALLK - Volume dodolan sing dikarepake perusahaan|HOOKIPA Pharma - Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan IGMS|iTeos Therapeutics - Prakiraan volume dodolan|Dodolan mangsa ngarep perusahaan oceanbiomedical.com OCEA|TC BioPharm (TCBP) - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan THRD
